The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).
 
Matthew E. Burge
Stock and Other Ownership Interests - coclear; CSL Limited; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
David Espinoza
No Relationships to Disclose
 
Katrin Marie Sjoquist
Honoraria - Astellas Pharma; Bayer (Inst); BMS; Lisata (Inst); Merck; MSD; Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech
 
Derrick HW Siu
No Relationships to Disclose
 
Rebecca Mercieca-Bebber
Research Funding - Amgen (Inst)
 
Lorraine A. Chantrill
Honoraria - Amgen; Amgen; Eisai; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - BMS Australia; MSD Oncology
 
Christos Stelios Karapetis
Honoraria - Eisai; MSD Oncology; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Gilead Sciences; Ipsen; Lilly; Merck Serono; Pierre Fabre; Roche; Takeda
 
Christopher B. Steer
Honoraria - AstraZeneca; Eisai; Novartis
Consulting or Advisory Role - Ipsen; Janssen; MSD; Sanofi
 
Sonia Yip
Travel, Accommodations, Expenses - Bayer
 
Jeff Cuff
No Relationships to Disclose
 
Stephanie Winata
No Relationships to Disclose
 
Jeanne Tie
Honoraria - Merck Serono; MSD Oncology; Pierre Fabre; SERVIER
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Haystack Oncology; Illumina; MSD Oncology; Roche; Takeda
Speakers' Bureau - MSD Oncology
 
Darshit Arunbhai Thaker
No Relationships to Disclose
 
Niall C. Tebbutt
Honoraria - AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Takeda
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Takeda